Literature DB >> 11545587

Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies.

H Bach1, Y Mazor, S Shaky, A Shoham-Lev, Y Berdichevsky, D L Gutnick, I Benhar.   

Abstract

Recombinant single-chain antibodies (scFvs) that are expressed in the cytoplasm of cells are of considerable biotechnological and therapeutic potential. However, the reducing environment of the cytoplasm inhibits the formation of the intradomain disulfide bonds that are essential for correct folding and functionality of these antibody fragments. Thus, scFvs expressed in the cytoplasm are mostly insoluble and inactive.Here, we describe a general approach for stabilizing scFvs for efficient functional expression in the cell cytoplasm in a soluble, active form. The scFvs are expressed as C-terminal fusions with the Escherichia coli maltose-binding protein (MBP). We tested a large panel of scFvs that were derived from hybridomas and from murine and human scFv phage display and expression libraries by comparing their stability and functionality as un-fused versus MBP fused proteins. We found that MBP fused scFvs are expressed at high levels in the cytoplasm of E. coli as soluble and active proteins regardless of the redox state of the bacterial cytoplasm. In contrast, most un-fused scFvs can be produced (to much lower levels) in a functional form only when expressed in trxB(-) but not in trxB(+) E. coli cells. We show that MBP-scFv fusions are more stable than the corresponding un-fused scFvs, and that they perform more efficiently in vivo as cytoplasmic intrabodies in E. coli. Thus, MBP seems to function as a molecular chaperone that promotes the solubility and stability of scFvs that are fused to it. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11545587     DOI: 10.1006/jmbi.2001.4914

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  49 in total

1.  Soluble overexpression and purification of bioactive human CCL2 in E. coli by maltose-binding protein.

Authors:  Thu Trang Thi Vu; Bon-Kyung Koo; Jung-A Song; Seon-Ha Chong; Cho Rong Park; Minh Tan Nguyen; Boram Jeong; Han-Bong Ryu; Jae Young Seong; Yeon Jin Jang; Robert Charles Robinson; Han Choe
Journal:  Mol Biol Rep       Date:  2014-11-13       Impact factor: 2.316

2.  Differential effects of supplementary affinity tags on the solubility of MBP fusion proteins.

Authors:  Karen M Routzahn; David S Waugh
Journal:  J Struct Funct Genomics       Date:  2002

3.  Expression of human proteins at the Southeast Collaboratory for Structural Genomics.

Authors:  Michael R Mayer; Tamara A Dailey; Clay M Baucom; Jill L Supernak; Michael C Grady; Harris E Hawk; Harry A Dailey
Journal:  J Struct Funct Genomics       Date:  2004

Review 4.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

5.  Prolactin/growth hormone-derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis.

Authors:  Ngoc-Quynh-Nhu Nguyen; Sebastien P Tabruyn; Laurence Lins; Michelle Lion; Anne M Cornet; Florence Lair; Francoise Rentier-Delrue; Robert Brasseur; Joseph A Martial; Ingrid Struman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

6.  N-terminal domains of native multidomain proteins have the potential to assist de novo folding of their downstream domains in vivo by acting as solubility enhancers.

Authors:  Chul Woo Kim; Kyoung Sim Han; Ki-Sun Ryu; Byung Hee Kim; Kyun-Hwan Kim; Seong Il Choi; Baik L Seong
Journal:  Protein Sci       Date:  2007-04       Impact factor: 6.725

7.  Gateway vectors for the production of combinatorially-tagged His6-MBP fusion proteins in the cytoplasm and periplasm of Escherichia coli.

Authors:  Sreedevi Nallamsetty; Brian P Austin; Kerri J Penrose; David S Waugh
Journal:  Protein Sci       Date:  2005-12       Impact factor: 6.725

8.  Expression and purification of recombinant tristetraprolin that can bind to tumor necrosis factor-alpha mRNA and serve as a substrate for mitogen-activated protein kinases.

Authors:  Heping Cao; Frederick Dzineku; Perry J Blackshear
Journal:  Arch Biochem Biophys       Date:  2003-04-01       Impact factor: 4.013

9.  Efficient isolation of soluble intracellular single-chain antibodies using the twin-arginine translocation machinery.

Authors:  Adam C Fisher; Matthew P DeLisa
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

10.  Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2009-05-14       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.